<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Ding S</submitter><pubmed_abstract>Ribonuclease H (RNase H), a critical functional protein in replication and genome stability, is emerging as a crucial therapeutic target for various diseases, including immune disorders. We present a transcription-based hybrid probe, referred to as Hybprobe, and a CRISPR/Cas12a signal amplifier for the rapid, sensitive, and low-cost detection of RNase H activity. In this method, the RNA strand of the Hybprobe is specifically cleaved by RNase H, releasing a single-stranded DNA activator that facilitates recognition and cleavage by the Cas12a/crRNA complex, triggering signal amplification via Cas12a's trans-cleavage activity. The proposed method demonstrates ultra-high sensitivity, capable of detecting RNase H as low as 9.02 × 10&lt;sup>-10&lt;/sup> U/μL, making it approximately 1,000 times more s</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>1589150</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12021801</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Ultrasensitive RNase H activity detection using the transcription-based hybrid probe and CRISPR/cas12a signal amplifier.</pubmed_title><pmcid>PMC12021801</pmcid><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Tang Z</pubmed_authors><pubmed_authors>Ding S</pubmed_authors><pubmed_authors>Ren K</pubmed_authors><pubmed_authors>Yang M</pubmed_authors><pubmed_authors>Shi J</pubmed_authors><pubmed_authors>Wei Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ultrasensitive RNase H activity detection using the transcription-based hybrid probe and CRISPR/cas12a signal amplifier.</name><description>Ribonuclease H (RNase H), a critical functional protein in replication and genome stability, is emerging as a crucial therapeutic target for various diseases, including immune disorders. We present a transcription-based hybrid probe, referred to as Hybprobe, and a CRISPR/Cas12a signal amplifier for the rapid, sensitive, and low-cost detection of RNase H activity. In this method, the RNA strand of the Hybprobe is specifically cleaved by RNase H, releasing a single-stranded DNA activator that facilitates recognition and cleavage by the Cas12a/crRNA complex, triggering signal amplification via Cas12a's trans-cleavage activity. The proposed method demonstrates ultra-high sensitivity, capable of detecting RNase H as low as 9.02 × 10&lt;sup>-10&lt;/sup> U/μL, making it approximately 1,000 times more s</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2025-07-09T03:04:52.561Z</modification><creation>2025-07-09T03:04:52.561Z</creation></dates><accession>S-EPMC12021801</accession><cross_references><pubmed>40290436</pubmed><doi>10.3389/fphar.2025.1589150</doi></cross_references></HashMap>